Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Doxorubicin/administration & dosage"" wg kryterium: Temat


Tytuł :
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2):a global, double-blind, randomised, phase 3 trial
Autorzy :
Horwitz, Steven
O'Connor, Owen A
Pro, Barbara
Illidge, Tim
Fanale, Michelle
Advani, Ranjana
Bartlett, Nancy L
Christensen, Jacob Haaber
Morschhauser, Franck
Domingo-Domenech, Eva
Rossi, Giuseppe
Kim, Won Seog
Feldman, Tatyana
Lennard, Anne
Belada, David
Illés, Árpád
Tobinai, Kensei
Tsukasaki, Kunihiro
Yeh, Su-Peng
Shustov, Andrei
Hüttmann, Andreas
Savage, Kerry J
Yuen, Sam
Iyer, Swaminathan
Zinzani, Pier Luigi
Hua, Zhaowei
Little, Meredith
Rao, Shangbang
Woolery, Joseph
Manley, Thomas
Trümper, Lorenz
Pokaż więcej
Temat :
Adult
Aged
Antineoplastic Agents/administration & dosage
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Cyclophosphamide/administration & dosage
Disease-Free Survival
Double-Blind Method
Doxorubicin/administration & dosage
Female
Humans
Immunoconjugates/administration & dosage
Immunologic Factors/administration & dosage
Intention to Treat Analysis
Lymphoma, Large-Cell, Anaplastic/drug therapy
Male
Middle Aged
Prednisone/administration & dosage
Vincristine/administration & dosage
Źródło :
Horwitz, S, O'Connor, O A, Pro, B, Illidge, T, Fanale, M, Advani, R, Bartlett, N L, Christensen, J H, Morschhauser, F, Domingo-Domenech, E, Rossi, G, Kim, W S, Feldman, T, Lennard, A, Belada, D, Illés, Á, Tobinai, K, Tsukasaki, K, Yeh, S-P, Shustov, A, Hüttmann, A, Savage, K J, Yuen, S, Iyer, S, Zinzani, P L, Hua, Z, Little, M, Rao, S, Woolery, J, Manley, T, Trümper, L & ECHELON-2 Study Group 2019, ' Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2) : a global, double-blind, randomised, phase 3 trial ', Lancet, vol. 393, no. 10168, pp. 229-240 . https://doi.org/10.1016/S0140-6736(18)32984-2
Tytuł :
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
Autorzy :
Manara, Maria Cristina
Valente, Sergio
Cristalli, Camilla
Nicoletti, Giordano
Landuzzi, Lorena
Zwergel, Clemens
Mazzone, Roberta
Stazi, Giulia
Arimondo, Paola
Pasello, Michela
Guerzoni, Clara
Picci, Piero
Nanni, Patrizia
Lollini, Pier-Luigi
Mai, Antonello
Scotlandi, Katia
Pokaż więcej
Temat :
MESH: Animals
MESH: Osteosarcoma/drug therapy
MESH: Osteosarcoma/metabolism
MESH: Quinolines/chemistry
MESH: Male
MESH: DNA (Cytosine-5-)-Methyltransferase 1/genetics
MESH: Antineoplastic Combined Chemotherapy Protocols/therapeutic use
DNA Methyltransferase Inhibitor
MESH: Osteosarcoma/genetics
MESH: Aminoquinolines/pharmacology
MESH: Tumor Burden/genetics
chemotherapy
epigenetics
MESH: Aminoquinolines/administration & dosage
MESH: Doxorubicin/administration & dosage
MESH: Enzyme Inhibitors/chemistry
[SDV.CAN]Life Sciences [q-bio]/Cancer
MESH: Bone Neoplasms/drug therapy
MESH: Enzyme Inhibitors/administration & dosage
MESH: Enzyme Inhibitors/pharmacology
MESH: Xenograft Model Antitumor Assays
MESH: Bone Neoplasms/genetics
MESH: Benzamides/pharmacology
MESH: Tumor Burden/drug effects
MESH: Cisplatin/administration & dosage
MESH: Humans
MESH: Bone Neoplasms/metabolism
DNA methylation
MESH: Gene Expression Regulation, Neoplastic/drug effects
patient-derived xenograft (PDX)
MESH: Mice, Knockout
MESH: DNA (Cytosine-5-)-Methyltransferase 1/antagonists & inhibitors
MESH: DNA (Cytosine-5-)-Methyltransferase 1/metabolism
MESH: Benzamides/administration & dosage
[CHIM.THER]Chemical Sciences/Medicinal Chemistry
osteosarcoma
MESH: Cell Line, Tumor
Źródło :
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics, American Association for Cancer Research, 2018, 17 (9), pp.1881-1892. ⟨10.1158/1535-7163.MCT-17-0818⟩
Opis pliku :
STAMPA
Tytuł :
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy
Autorzy :
Manara, Maria Cristina
Valente, Sergio
Cristalli, Camilla
Nicoletti, Giordano
Landuzzi, Lorena
Zwergel, Clemens
Mazzone, Roberta
Stazi, Giulia
Arimondo, Paola
Pasello, Michela
Guerzoni, Clara
Picci, Piero
Nanni, Patrizia
Lollini, Pier-Luigi
Mai, Antonello
Scotlandi, Katia
Pokaż więcej
Temat :
MESH: Aminoquinolines/administration & dosage
MESH: Aminoquinolines/pharmacology
MESH: Cisplatin/administration & dosage
MESH: DNA (Cytosine-5-)-Methyltransferase 1/antagonists & inhibitors
MESH: DNA (Cytosine-5-)-Methyltransferase 1/genetics
MESH: DNA (Cytosine-5-)-Methyltransferase 1/metabolism
MESH: Doxorubicin/administration & dosage
MESH: Enzyme Inhibitors/administration & dosage
MESH: Enzyme Inhibitors/chemistry
MESH: Enzyme Inhibitors/pharmacology
MESH: Gene Expression Regulation, Neoplastic/drug effects
MESH: Humans
MESH: Animals
MESH: Male
MESH: Mice, Knockout
MESH: Osteosarcoma/drug therapy
MESH: Osteosarcoma/genetics
MESH: Osteosarcoma/metabolism
MESH: Quinolines/chemistry
MESH: Tumor Burden/drug effects
MESH: Tumor Burden/genetics
MESH: Xenograft Model Antitumor Assays
MESH: Antineoplastic Combined Chemotherapy Protocols/therapeutic use
MESH: Benzamides/administration & dosage
MESH: Benzamides/pharmacology
MESH: Bone Neoplasms/drug therapy
MESH: Bone Neoplasms/genetics
MESH: Bone Neoplasms/metabolism
MESH: Cell Line, Tumor
[CHIM.THER]Chemical Sciences/Medicinal Chemistry
[SDV.CAN]Life Sciences [q-bio]/Cancer
Źródło :
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics, American Association for Cancer Research, 2018, 17 (9), pp.1881-1892. ⟨10.1158/1535-7163.MCT-17-0818⟩
Tytuł :
Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.
Autorzy :
Pedersen, Mette Ølgod
Gang, Anne Ortved
Brown, Peter
Pedersen, Michael
Knudsen, Helle
Nielsen, Signe Ledou
Poulsen, Tim
Wirenfeldt Klausen, Tobias
Høgdall, Estrid
Nørgaard, Peter
Pokaż więcej
Temat :
Retrospective Studies
Fluorescent in Situ Hybridization
Prednisone/administration & dosage
Danish People
Vincristine/administration & dosage
Young Adult
Proto-Oncogene Proteins c-bcl-6/genetics
Oncology
Population Groupings
hemic and lymphatic diseases
White Blood Cells
Molecular Biology Techniques
Probe Hybridization
Pharmacology
Cyclophosphamide
Female
Protein Expression
Immunology
Immunohistochemistry Techniques
Cellular Types
Risk Factors
Biology and Life Sciences
Biomarkers
Blood Cells
Animal Cells
Proto-Oncogene Proteins c-bcl-2/genetics
Biomarkers, Tumor/genetics
Immunologic Techniques
European People
In Situ Hybridization, Fluorescence
Ethnicities
Cytogenetic Techniques
Science
Adolescent
Etoposide/administration & dosage
Adult
Male
Molecular Biology
Research Article
Molecular Biology Assays and Analysis Techniques
Gene Expression and Vector Techniques
Kaplan-Meier Estimate
Proto-Oncogene Proteins c-myc/genetics
Antibody-Producing Cells
People and Places
Cyclophosphamide/administration & dosage
Cancers and Neoplasms
Immunohistochemistry
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Drugs
Hematologic Cancers and Related Disorders
Research and Analysis Methods
Lymphomas
Immune Cells
Medicine
Middle Aged
Prognosis
Doxorubicin/administration & dosage
Histochemistry and Cytochemistry Techniques
Hematology
Cell Biology
B Cells
Molecular Probe Techniques
Biochemistry
immune system diseases
Antibodies, Monoclonal, Murine-Derived/administration & dosage
Journal Article
Medicine and Health Sciences
Humans
Lymphoma, Large B-Cell, Diffuse/diagnosis
Źródło :
PLoS ONE, Vol 12, Iss 10, p e0186983 (2017)
Pedersen, M Ø, Gang, A O, Brown, P, Pedersen, M, Knudsen, H, Nielsen, S L, Poulsen, T, Wirenfeldt Klausen, T, Høgdall, E & Nørgaard, P 2017, ' Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers ', PloS one, vol. 12, no. 10, e0186983 . https://doi.org/10.1371/journal.pone.0186983
Opis pliku :
application/pdf
Tytuł :
Ventricular arrhythmia and torsade de pointe: Dose limiting toxicities of the MDR-modulator S9788 in a phase I trial
Autorzy :
Stupp, R.
Bauer, J.
Pagani, O.
Gerard, B.
Cerny, T.
Sessa, C.
Bastian, G.
Sarkany, M.
Schläpfer, J.
Giroux, B.
Leyvraz, S.
Pokaż więcej
Temat :
Adult
Aged
Antineoplastic Agents/administration & dosage
Antineoplastic Agents/adverse effects
Arrhythmias, Cardiac/chemically induced
Doxorubicin/administration & dosage
Drug Administration Schedule
Electrocardiography
Female
Humans
Male
Middle Aged
Piperidines/administration & dosage
Piperidines/adverse effects
Torsades de Pointes/chemically induced
Triazines/administration & dosage
Triazines/adverse effects
Źródło :
Annals of Oncology, vol. 9, no. 11, pp. 1233-1242
Stupp, R.; Bauer, J.; Pagani, O.; Gerard, B.; Cerny, T.; Sessa, C.; Bastian, G.; Sarkany, M.; Schläpfer, J.; Giroux, B.; Leyvraz, S. (1998). Ventricular arrhythmia and torsade de pointe: Dose limiting toxicities of the MDR-modulator S9788 in a phase I trial. Annals of oncology, 9(11), pp. 1233-1242. Oxford University Press 10.1023/A:1008495919071
Opis pliku :
application/pdf
Tytuł :
The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma:An international multicenter study of 1532 patients treated with chemoimmunotherapy
Autorzy :
El-Galaly, Tarec Christoffer
Villa, Diego
Michaelsen, Thomas Yssing
Hutchings, Martin
Mikhaeel, Nabegh George
Savage, Kerry J.
Sehn, Laurie H.
Barrington, Sally
Hansen, Jakob W.
Smith, Daniel
Rady, Kirsty
Mylam, Karen J.
Larsen, Thomas S.
Holmberg, Staffan
Juul, Maja B.
Cordua, Sabrina
Clausen, Michael R.
Jensen, Kristina B.
Johnsen, Hans E.
Seymour, John F.
Connors, Joseph M.
de Nully Brown, Peter
Bøgsted, Martin
Cheah, Chan Y.
Pokaż więcej
Temat :
CNS relapse
Retrospective Studies
Secondary CNS involvement
Prednisone/administration & dosage
PET/CT
diffuse large B-cell lymphoma
Immunotherapy/methods
Central Nervous System Neoplasms/diagnostic imaging
Vincristine/administration & dosage
Young Adult
CNS-IPI
Cyclophosphamide/administration & dosage
extra nodal
Combined Modality Therapy
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Rituximab
Risk Factors
PET/CT imaging
Aged
CNS prophylaxis
Middle Aged
Prognosis
Treatment Outcome
Lymphoma, Large B-Cell, Diffuse/diagnostic imaging
Positron Emission Tomography Computed Tomography
Doxorubicin/administration & dosage
Neoplasm Recurrence, Local/diagnostic imaging
Antibodies, Monoclonal, Murine-Derived/administration & dosage
Adolescent
Journal Article
Aged, 80 and over
Adult
Humans
Male
Źródło :
El-Galaly, T C, Villa, D, Michaelsen, T Y, Hutchings, M, Mikhaeel, N G, Savage, K J, Sehn, L H, Barrington, S, Hansen, J W, Smith, D, Rady, K, Juul Mylam, K, Larsen, T S, Holmberg, S, Juul, M B, Cordua, S, Clausen, M R, Jensen, K B, Johnsen, H E, Seymour, J F, Connors, J M, de Nully Brown, P, Bøgsted, M & Cheah, C Y 2017, ' The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma : An international multicenter study of 1532 patients treated with chemoimmunotherapy ', European journal of cancer (Oxford, England : 1990), vol. 75, pp. 195-203 . https://doi.org/10.1016/j.ejca.2016.12.029
El-Galaly, T C, Villa, D, Michaelsen, T Y, Hutchings, M, Mikhaeel, N G, Savage, K J, Sehn, L H, Barrington, S, Hansen, J W, Smith, D, Rady, K, Juul Mylam, K, Larsen, T S, Holmberg, S, Juul, M B, Cordua, S, Clausen, M R, Buchardi Jensen, K, Johnsen, H E, Seymour, J F, Connors, J M, de Nully Brown, P, Bøgsted, M & Cheah, C Y 2017, ' The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma : An international multicenter study of 1532 patients treated with chemoimmunotherapy ', European Journal of Cancer, vol. 75, pp. 195-203 . https://doi.org/10.1016/j.ejca.2016.12.029
El-Galaly, T C, Villa, D, Michaelsen, T Y, Hutchings, M, Mikhaeel, N G, Savage, K J, Sehn, L H, Barrington, S, Hansen, J W, Smith, D, Rady, K, Mylam, K J, Larsen, T S, Holmberg, S, Juul, M B, Cordua, S, Clausen, M R, Jensen, K B, Johnsen, H E, Seymour, J F, Connors, J M, de Nully Brown, P, Bøgsted, M & Cheah, C Y 2017, ' The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma : An international multicenter study of 1532 patients treated with chemoimmunotherapy ' European Journal of Cancer, vol. 75, pp. 195-203 . https://doi.org/10.1016/j.ejca.2016.12.029
El-Galaly, T C, Villa, D, Michaelsen, T Y, Hutchings, M, Mikhaeel, N G, Savage, K J, Sehn, L H, Barrington, S, Hansen, J W, Smith, D, Rady, K, Mylam, K J, Larsen, T S, Holmberg, S, Juul, M B, Cordua, S, Clausen, M R, Jensen, K B, Johnsen, H E, Seymour, J F, Connors, J M, de Nully Brown, P, Bøgsted, M & Cheah, C Y 2017, ' The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma : An international multicenter study of 1532 patients treated with chemoimmunotherapy ', European Journal of Cancer, vol. 75, pp. 195-203 . https://doi.org/10.1016/j.ejca.2016.12.029
Opis pliku :
application/pdf
Tytuł :
Doxorubicin-Induced Gut Toxicity in Piglets fed Bovine Milk and Colostrum
Autorzy :
Shen, René Liang
Rathe, Mathias
Jiang, Pingping
Pontoppidan, Peter Erik Lotko
Heegaard, Peter M H
Müller, Klaus
Sangild, Per Torp
Pokaż więcej
Temat :
Bovine colostrum
Chemotherapy
Gastrointestinal toxicity
Mucositis
Porcine
C-Reactive Protein
Antibiotics, Antineoplastic/administration & dosage
Colostrum/drug effects
Intestinal Mucosa/drug effects
Milk/metabolism
Animals
Cattle
Swine
Doxorubicin/administration & dosage
Female
Weight Gain
Źródło :
Shen, R L, Rathe, M, Jiang, P, Pontoppidan, P E L, Heegaard, P M H, Müller, K & Sangild, P T 2016, ' Doxorubicin-Induced Gut Toxicity in Piglets fed Bovine Milk and Colostrum ', Journal of Pediatric Gastroenterology and Nutrition, vol. 63, no. 6, pp. 698-707 . https://doi.org/10.1097/MPG.0000000000001205
Tytuł :
Secondary infiltration of the central nervous system in patients with diffuse large B-cell lymphoma
Autorzy :
Rocha,Talita Maira Bueno da Silveira da
Costa,Fortier Sergio
Pinto,Maeva Seo Gomes
Silva,Igor Campos da
Paes,Roberto Pinto
Chiattone,Carlos Sergio
Pokaż więcej
Temat :
Doxorubicin/administration & dosage
Original Article
Risk factors
Antineoplastic Agents/therapeutic use
Central nervous system neoplasms/secondary
Lymphoma, large B-cell, diffuse
Diseases of the blood and blood-forming organs
RC633-647.5
Multivariate analysis
Drug administration schedule
Źródło :
Revista Brasileira de Hematologia e Hemoterapia v.35 n.4 2013
Revista Brasileira de Hematologia e Hemoterapia, Vol 35, Iss 4, Pp 256-262 (2013)
Revista Brasileira de Hematologia e Hemoterapia
Revista Brasileira de Hematologia e Hemoterapia, Volume: 35, Issue: 4, Pages: 256-262, Published: 2013
Opis pliku :
text/html

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies